| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.896 | 0.002 | 0.896 | Diuretic | 0.473 0.009 DBMET02065 0.544 0.006 DBMET02066 0.302 0.022 DBMET02067 | ||
| 0.751 | 0.005 | 0.751 | Antithrombotic | 0.471 0.034 DBMET02065 0.438 0.04 DBMET02066 0.35 0.064 DBMET02067 | ||
| 0.734 | 0.002 | 0.734 | Cathepsin G inhibitor | 0.261 0.012 DBMET02065 0.126 0.025 DBMET02066 0.253 0.012 DBMET02067 | ||
| 0.675 | 0.002 | 0.675 | Antidiuretic hormone antagonist | 0.037 0.029 DBMET02065 0.241 0.005 DBMET02067 | ||
| 0.657 | 0.007 | 0.73 | Interleukin antagonist | 0.722 0.004 DBMET02065 0.689 0.005 DBMET02066 0.73 0.004 DBMET02067 | DBMET02067 | |
| 0.645 | 0.002 | 0.645 | Vasopressin 1 antagonist | 0.191 0.005 DBMET02067 | ||
| 0.638 | 0.001 | 0.638 | Antidiuretic hormone agonist | 0.035 0.01 DBMET02065 0.27 0.003 DBMET02067 | ||
| 0.635 | 0.002 | 0.635 | Oxytocin antagonist | 0.074 0.013 DBMET02065 0.198 0.005 DBMET02067 | ||
| 0.602 | 0.003 | 0.602 | Hemostatic | 0.3 0.016 DBMET02065 0.181 0.042 DBMET02066 0.397 0.008 DBMET02067 | ||
| 0.591 | 0.003 | 0.591 | Vasopressin 1A antagonist | 0.096 0.005 DBMET02067 | ||
| 0.538 | 0.001 | 0.538 | Vasopressin 2 agonist | 0.017 0.011 DBMET02065 0.174 0.003 DBMET02067 | ||
| 0.535 | 0.003 | 0.535 | Erythropoietin receptor agonist | 0.056 0.019 DBMET02065 0.096 0.011 DBMET02067 | ||
| 0.512 | 0.002 | 0.512 | Vasopressin 2 antagonist | 0.107 0.005 DBMET02067 | ||
| 0.517 | 0.022 | 0.517 | Calcium channel L-type activator | |||
| 0.496 | 0.002 | 0.496 | Vasopressin 1B antagonist | 0.19 0.004 DBMET02067 | ||
| 0.491 | 0.043 | 0.491 | Antibacterial | 0.427 0.065 DBMET02067 | ||
| 0.445 | 0.016 | 0.48 | Insulysin inhibitor | 0.475 0.012 DBMET02065 0.408 0.021 DBMET02066 0.48 0.011 DBMET02067 | DBMET02067 | |
| 0.45 | 0.037 | 0.862 | Immunostimulant | 0.862 0.003 DBMET02065 0.77 0.005 DBMET02066 0.537 0.024 DBMET02067 | DBMET02065 | |
| 0.43 | 0.02 | 0.579 | Interleukin 2 agonist | 0.303 0.072 DBMET02065 0.305 0.07 DBMET02066 0.579 0.004 DBMET02067 | DBMET02067 | |
| 0.396 | 0.001 | 0.396 | Vasopressin 1 agonist | 0.027 0.008 DBMET02065 0.059 0.002 DBMET02067 | ||
| 0.39 | 0.001 | 0.39 | Vasopressin 1A agonist | 0.04 0.005 DBMET02065 0.074 0.002 DBMET02067 | ||
| 0.369 | 0.005 | 0.369 | Acetylcholine nicotinic antagonist | 0.082 0.052 DBMET02067 | ||
| 0.363 | 0.004 | 0.363 | Somatostatin agonist | 0.039 0.017 DBMET02065 0.187 0.005 DBMET02067 | ||
| 0.334 | 0.002 | 0.334 | Somatostatin 2 antagonist | 0.046 0.016 DBMET02065 0.153 0.005 DBMET02067 | ||
| 0.329 | 0.005 | 0.329 | Neuronal nicotinic receptor antagonist | 0.074 0.041 DBMET02067 | ||
| 0.32 | 0.002 | 0.32 | Somatostatin 4 antagonist | 0.024 0.016 DBMET02065 0.091 0.005 DBMET02067 | ||
| 0.318 | 0.003 | 0.318 | Somatostatin 1 agonist | 0.169 0.01 DBMET02065 0.164 0.011 DBMET02066 0.234 0.005 DBMET02067 | ||
| 0.359 | 0.057 | 0.545 | Immunomodulator | 0.359 0.057 DBMET02065 0.334 0.065 DBMET02066 0.545 0.017 DBMET02067 | DBMET02067 | |
| 0.304 | 0.003 | 0.304 | Nav1.4 sodium channel blocker | 0.194 0.02 DBMET02065 0.157 0.031 DBMET02066 0.266 0.006 DBMET02067 | ||
| 0.307 | 0.013 | 0.307 | Adenylate cyclase inhibitor | 0.183 0.029 DBMET02065 0.234 0.021 DBMET02067 | ||
| 0.315 | 0.025 | 0.424 | Calpain inhibitor | 0.424 0.006 DBMET02065 0.352 0.016 DBMET02066 0.309 0.027 DBMET02067 | DBMET02065 | |
| 0.292 | 0.003 | 0.292 | Somatostatin 5 antagonist | 0.05 0.013 DBMET02065 0.039 0.019 DBMET02066 0.099 0.006 DBMET02067 | ||
| 0.288 | 0.004 | 0.288 | Factor XII inhibitor | 0.164 0.01 DBMET02065 0.146 0.014 DBMET02066 0.209 0.005 DBMET02067 | ||
| 0.28 | 0.012 | 0.334 | Proteasome inhibitor | 0.334 0.007 DBMET02065 0.237 0.017 DBMET02066 0.22 0.02 DBMET02067 | DBMET02065 | |
| 0.262 | 0.002 | 0.262 | Somatostatin 1 antagonist | 0.057 0.016 DBMET02065 0.038 0.027 DBMET02066 0.13 0.005 DBMET02067 | ||
| 0.257 | 0.003 | 0.257 | Growth hormone release inhibitor | 0.134 0.005 DBMET02065 0.094 0.007 DBMET02066 0.147 0.005 DBMET02067 | ||
| 0.266 | 0.03 | 0.539 | Thrombolytic | 0.426 0.009 DBMET02065 0.367 0.015 DBMET02066 0.539 0.005 DBMET02067 | DBMET02067 | |
| 0.331 | 0.097 | 0.331 | Immunosuppressant | 0.239 0.157 DBMET02065 0.243 0.153 DBMET02066 0.304 0.112 DBMET02067 | ||
| 0.227 | 0.006 | 0.262 | Melanocortin antagonist | 0.061 0.02 DBMET02065 0.043 0.039 DBMET02066 0.262 0.005 DBMET02067 | DBMET02067 | |
| 0.274 | 0.062 | 0.341 | Platelet antagonist | 0.252 0.071 DBMET02065 0.244 0.075 DBMET02066 0.341 0.04 DBMET02067 | DBMET02067 | |
| 0.234 | 0.023 | 0.234 | Acetylcholine antagonist | |||
| 0.232 | 0.024 | 0.232 | Cholinergic antagonist | |||
| 0.242 | 0.04 | 0.458 | Anticoagulant | 0.363 0.02 DBMET02065 0.29 0.03 DBMET02066 0.458 0.012 DBMET02067 | DBMET02067 | |
| 0.22 | 0.028 | 0.23 | Nav1.2 sodium channel blocker | 0.23 0.026 DBMET02067 | DBMET02067 | |
| 0.192 | 0.011 | 0.294 | CXC chemokine 4 receptor antagonist | 0.294 0.005 DBMET02067 | DBMET02067 | |
| 0.186 | 0.007 | 0.186 | Melanocortin 1 antagonist | 0.083 0.013 DBMET02065 0.153 0.008 DBMET02067 | ||
| 0.205 | 0.028 | 0.465 | Histone deacetylase SIRT1 inhibitor | 0.236 0.02 DBMET02065 0.21 0.027 DBMET02066 0.465 0.004 DBMET02067 | DBMET02067 | |
| 0.184 | 0.01 | 0.184 | Chymotrypsin inhibitor | 0.169 0.013 DBMET02065 0.145 0.018 DBMET02066 0.144 0.018 DBMET02067 | ||
| 0.184 | 0.014 | 0.387 | Opioid delta receptor antagonist | 0.188 0.013 DBMET02065 0.129 0.024 DBMET02066 0.387 0.004 DBMET02067 | DBMET02067 | |
| 0.17 | 0.004 | 0.17 | Somatostatin 5 agonist | 0.039 0.019 DBMET02065 0.129 0.004 DBMET02067 | ||
| 0.273 | 0.106 | 0.442 | Apoptosis antagonist | 0.432 0.031 DBMET02065 0.41 0.035 DBMET02066 0.442 0.029 DBMET02067 | DBMET02067 | |
| 0.235 | 0.077 | 0.651 | Angiogenesis stimulant | 0.448 0.015 DBMET02065 0.419 0.019 DBMET02066 0.651 0.005 DBMET02067 | DBMET02067 | |
| 0.163 | 0.006 | 0.38 | Nicotinic receptor alpha3 subunit antagonist | 0.38 0.003 DBMET02065 0.185 0.005 DBMET02066 0.089 0.011 DBMET02067 | DBMET02065 | |
| 0.154 | 0.003 | 0.154 | Somatostatin 3 antagonist | 0.054 0.006 DBMET02067 | ||
| 0.149 | 0 | 0.149 | Oxytocin agonist | 0.079 0.004 DBMET02065 0.053 0.022 DBMET02066 0.08 0.004 DBMET02067 | ||
| 0.222 | 0.074 | 0.422 | Peptidyltransferase inhibitor | 0.243 0.056 DBMET02065 0.422 0.005 DBMET02067 | DBMET02067 | |
| 0.167 | 0.021 | 0.411 | Opioid antagonist | 0.198 0.014 DBMET02065 0.142 0.028 DBMET02066 0.411 0.004 DBMET02067 | DBMET02067 | |
| 0.148 | 0.004 | 0.148 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.031 DBMET02065 0.034 0.029 DBMET02066 | ||
| 0.15 | 0.009 | 0.186 | Melanocortin 3 antagonist | 0.025 0.022 DBMET02065 0.186 0.007 DBMET02067 | DBMET02067 | |
| 0.148 | 0.007 | 0.233 | Melanocortin 4 antagonist | 0.053 0.022 DBMET02065 0.233 0.005 DBMET02067 | DBMET02067 | |
| 0.142 | 0.006 | 0.142 | Leukocyte elastase inhibitor | 0.085 0.012 DBMET02065 0.12 0.008 DBMET02066 0.039 0.034 DBMET02067 | ||
| 0.15 | 0.017 | 0.361 | Opioid mu receptor antagonist | 0.162 0.015 DBMET02065 0.108 0.029 DBMET02066 0.361 0.004 DBMET02067 | DBMET02067 | |
| 0.142 | 0.01 | 0.174 | Glucagon-like peptide 1 agonist | 0.174 0.005 DBMET02065 0.139 0.011 DBMET02066 0.167 0.006 DBMET02067 | DBMET02065 | |
| 0.127 | 0.006 | 0.143 | Calcitonin receptor agonist | 0.143 0.003 DBMET02065 0.121 0.007 DBMET02066 0.112 0.008 DBMET02067 | DBMET02065 | |
| 0.167 | 0.046 | 0.224 | Neurotrophic factor | 0.193 0.031 DBMET02065 0.224 0.018 DBMET02066 0.216 0.021 DBMET02067 | DBMET02066 | |
| 0.191 | 0.076 | 0.216 | Platelet adhesion inhibitor | 0.148 0.108 DBMET02065 0.216 0.063 DBMET02067 | DBMET02067 | |
| 0.125 | 0.013 | 0.125 | Integrin antagonist | |||
| 0.129 | 0.019 | 0.398 | Hematopoietic | 0.195 0.01 DBMET02065 0.131 0.018 DBMET02066 0.398 0.004 DBMET02067 | DBMET02067 | |
| 0.177 | 0.069 | 0.58 | Growth hormone agonist | 0.44 0.011 DBMET02065 0.392 0.017 DBMET02066 0.58 0.004 DBMET02067 | DBMET02067 | |
| 0.115 | 0.007 | 0.119 | Melanocortin 5 antagonist | 0.119 0.007 DBMET02067 | DBMET02067 | |
| 0.242 | 0.137 | 0.242 | Sodium/bile acid cotransporter inhibitor | |||
| 0.105 | 0.004 | 0.105 | Growth hormone releasing factor antagonist | 0.05 0.007 DBMET02065 0.038 0.01 DBMET02066 0.068 0.005 DBMET02067 | ||
| 0.11 | 0.016 | 0.14 | Plasmin inhibitor | 0.082 0.021 DBMET02065 0.051 0.031 DBMET02066 0.14 0.011 DBMET02067 | DBMET02067 | |
| 0.095 | 0.005 | 0.095 | Kallikrein 7 inhibitor | |||
| 0.14 | 0.053 | 0.14 | Cell adhesion inhibitor | 0.107 0.077 DBMET02065 0.108 0.076 DBMET02066 | ||
| 0.098 | 0.01 | 0.098 | Neurokinin 2 antagonist | 0.064 0.018 DBMET02067 | ||
| 0.096 | 0.011 | 0.096 | Kallikrein inhibitor | 0.044 0.037 DBMET02065 0.092 0.012 DBMET02067 | ||
| 0.09 | 0.007 | 0.09 | Somatostatin 4 agonist | 0.07 0.01 DBMET02067 | ||
| 0.192 | 0.111 | 0.192 | Vasodilator | |||
| 0.088 | 0.009 | 0.148 | Melanocortin agonist | 0.029 0.017 DBMET02065 0.148 0.005 DBMET02067 | DBMET02067 | |
| 0.086 | 0.009 | 0.146 | Melanocortin 1 agonist | 0.037 0.016 DBMET02065 0.146 0.005 DBMET02067 | DBMET02067 | |
| 0.085 | 0.007 | 0.085 | VLA-4 antagonist | |||
| 0.082 | 0.006 | 0.082 | Integrin alpha5beta1 antagonist | 0.059 0.012 DBMET02065 0.054 0.015 DBMET02066 0.057 0.013 DBMET02067 | ||
| 0.116 | 0.043 | 0.239 | Factor V inhibitor | 0.143 0.022 DBMET02065 0.116 0.043 DBMET02066 0.239 0.003 DBMET02067 | DBMET02067 | |
| 0.09 | 0.019 | 0.124 | GP IIb/IIIa receptor antagonist | 0.044 0.038 DBMET02065 0.124 0.014 DBMET02067 | DBMET02067 | |
| 0.13 | 0.061 | 0.398 | Histone deacetylase class III inhibitor | 0.168 0.032 DBMET02065 0.146 0.047 DBMET02066 0.398 0.004 DBMET02067 | DBMET02067 | |
| 0.088 | 0.023 | 0.101 | Trypsin inhibitor | 0.069 0.035 DBMET02065 0.058 0.054 DBMET02066 0.101 0.016 DBMET02067 | DBMET02067 | |
| 0.081 | 0.016 | 0.081 | Neurokinin antagonist | |||
| 0.092 | 0.029 | 0.187 | Neuropeptide agonist | 0.187 0.005 DBMET02065 0.171 0.008 DBMET02066 0.175 0.007 DBMET02067 | DBMET02065 | |
| 0.073 | 0.013 | 0.1 | Growth hormone secretagogue receptor agonist | 0.1 0.007 DBMET02067 | DBMET02067 | |
| 0.076 | 0.019 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.115 | 0.06 | 0.115 | EphA2 antagonist | |||
| 0.06 | 0.005 | 0.069 | Urotensin II agonist | 0.069 0.004 DBMET02067 | DBMET02067 | |
| 0.158 | 0.104 | 0.158 | P-glycoprotein inhibitor | |||
| 0.074 | 0.021 | 0.104 | Kallikrein 1 inhibitor | 0.078 0.019 DBMET02065 0.068 0.026 DBMET02066 0.104 0.011 DBMET02067 | DBMET02067 | |
| 0.061 | 0.009 | 0.111 | Melanocortin 4 agonist | 0.021 0.019 DBMET02065 0.111 0.005 DBMET02067 | DBMET02067 | |
| 0.084 | 0.038 | 0.133 | Thrombin inhibitor | 0.109 0.021 DBMET02065 0.085 0.037 DBMET02066 0.133 0.014 DBMET02067 | DBMET02067 | |
| 0.066 | 0.022 | 0.291 | Neurotensin receptor antagonist | 0.205 0.006 DBMET02065 0.1 0.014 DBMET02066 0.291 0.004 DBMET02067 | DBMET02067 | |
| 0.049 | 0.005 | 0.049 | Motilin receptor antagonist | 0.025 0.024 DBMET02065 0.03 0.015 DBMET02067 | ||
| 0.135 | 0.09 | 0.266 | Neuropeptide Y1 antagonist | 0.266 0.007 DBMET02065 0.204 0.017 DBMET02066 0.218 0.013 DBMET02067 | DBMET02065 | |
| 0.054 | 0.011 | 0.07 | Melanocortin 3 agonist | 0.07 0.009 DBMET02067 | DBMET02067 | |
| 0.047 | 0.006 | 0.047 | Growth factor receptor-bound protein 2 antagonist | 0.04 0.014 DBMET02065 0.04 0.014 DBMET02066 0.041 0.013 DBMET02067 | ||
| 0.101 | 0.064 | 0.213 | Protease inhibitor | 0.213 0.012 DBMET02065 0.201 0.014 DBMET02066 0.173 0.021 DBMET02067 | DBMET02065 | |
| 0.041 | 0.004 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 DBMET02067 | ||
| 0.041 | 0.004 | 0.041 | Somatostatin 2 agonist | 0.018 0.007 DBMET02067 | ||
| 0.06 | 0.024 | 0.271 | Opioid mu receptor agonist | 0.079 0.018 DBMET02065 0.042 0.037 DBMET02066 0.271 0.004 DBMET02067 | DBMET02067 | |
| 0.147 | 0.111 | 0.545 | Amyloid beta aggregation inhibitor | 0.315 0.042 DBMET02065 0.195 0.08 DBMET02066 0.545 0.01 DBMET02067 | DBMET02067 | |
| 0.047 | 0.012 | 0.112 | Melanocortin 5 agonist | 0.112 0.007 DBMET02067 | DBMET02067 | |
| 0.048 | 0.017 | 0.141 | Cholecystokinin B agonist | 0.055 0.014 DBMET02065 0.043 0.021 DBMET02066 0.141 0.005 DBMET02067 | DBMET02067 | |
| 0.043 | 0.013 | 0.043 | Integrin alpha4 antagonist | |||
| 0.038 | 0.008 | 0.038 | Integrin beta7 antagonist | |||
| 0.04 | 0.012 | 0.04 | Cyclophilin A inhibitor | |||
| 0.035 | 0.007 | 0.035 | Integrin beta5 antagonist | |||
| 0.087 | 0.059 | 0.087 | Interleukin 5 antagonist | |||
| 0.097 | 0.07 | 0.119 | Nav1.1 sodium channel blocker | 0.119 0.049 DBMET02067 | DBMET02067 | |
| 0.047 | 0.021 | 0.047 | Neurokinin 1 antagonist | |||
| 0.042 | 0.016 | 0.042 | Histone deacetylase 11 inhibitor | |||
| 0.042 | 0.016 | 0.042 | Histone deacetylase class IV inhibitor | |||
| 0.027 | 0.005 | 0.027 | Somatostatin 3 agonist | |||
| 0.06 | 0.039 | 0.121 | Gonadotropin-releasing hormone receptor agonist | 0.084 0.015 DBMET02065 0.06 0.039 DBMET02066 0.121 0.006 DBMET02067 | DBMET02067 | |
| 0.055 | 0.035 | 0.08 | Elastase inhibitor | 0.08 0.017 DBMET02065 0.069 0.023 DBMET02066 | DBMET02065 | |
| 0.03 | 0.01 | 0.05 | Aminopeptidase P inhibitor | 0.05 0.004 DBMET02065 0.04 0.005 DBMET02066 0.035 0.007 DBMET02067 | DBMET02065 | |
| 0.019 | 0 | 0.019 | Vasopressin 1B agonist | |||
| 0.059 | 0.041 | 0.151 | Cathepsin E inhibitor | 0.127 0.007 DBMET02065 0.151 0.005 DBMET02066 0.077 0.024 DBMET02067 | DBMET02066 | |
| 0.042 | 0.024 | 0.042 | Substance P antagonist | 0.039 0.028 DBMET02067 | ||
| 0.033 | 0.015 | 0.119 | Bradykinin B2 receptor agonist | 0.056 0.006 DBMET02065 0.035 0.015 DBMET02066 0.119 0.003 DBMET02067 | DBMET02067 | |
| 0.035 | 0.018 | 0.035 | Histone deacetylase 10 inhibitor | |||
| 0.043 | 0.027 | 0.291 | Neurokinin 2 agonist | 0.072 0.008 DBMET02065 0.052 0.018 DBMET02066 0.291 0.003 DBMET02067 | DBMET02067 | |
| 0.178 | 0.164 | 0.602 | Neuropeptide Y2 antagonist | 0.602 0.004 DBMET02065 0.338 0.01 DBMET02066 0.334 0.01 DBMET02067 | DBMET02065 | |
| 0.033 | 0.019 | 0.088 | Factor VII inhibitor | 0.026 0.024 DBMET02065 0.088 0.008 DBMET02067 | DBMET02067 | |
| 0.047 | 0.034 | 0.084 | Urokinase inhibitor | 0.084 0.02 DBMET02067 | DBMET02067 | |
| 0.034 | 0.021 | 0.034 | Histone deacetylase 4 inhibitor | |||
| 0.197 | 0.185 | 0.307 | Vasodilator, coronary | 0.307 0.082 DBMET02067 | DBMET02067 | |
| 0.039 | 0.028 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.031 DBMET02065 0.041 0.023 DBMET02067 | DBMET02067 | |
| 0.016 | 0.004 | 0.016 | Immunosuppressant Cyclosporine-like | |||
| 0.034 | 0.023 | 0.041 | Plasma kallikrein inhibitor | 0.041 0.018 DBMET02067 | DBMET02067 | |
| 0.056 | 0.046 | 0.153 | Bombesin 1 receptor agonist | 0.095 0.019 DBMET02065 0.077 0.027 DBMET02066 0.153 0.008 DBMET02067 | DBMET02067 | |
| 0.05 | 0.042 | 0.132 | Cathepsin D inhibitor | 0.132 0.01 DBMET02065 0.13 0.01 DBMET02066 0.078 0.025 DBMET02067 | DBMET02065 | |
| 0.034 | 0.026 | 0.17 | Opioid delta receptor agonist | 0.041 0.018 DBMET02065 0.17 0.004 DBMET02067 | DBMET02067 | |
| 0.049 | 0.041 | 0.242 | Opioid agonist | 0.081 0.018 DBMET02065 0.053 0.036 DBMET02066 0.242 0.005 DBMET02067 | DBMET02067 | |
| 0.134 | 0.128 | 0.174 | Hepatoprotectant | 0.152 0.108 DBMET02065 0.174 0.085 DBMET02066 | DBMET02066 | |
| 0.032 | 0.028 | 0.038 | Calpain 1 inhibitor | 0.035 0.018 DBMET02065 0.032 0.026 DBMET02066 0.038 0.013 DBMET02067 | DBMET02067 | |
| 0.015 | 0.011 | 0.015 | Integrin alpha4beta1 antagonist | |||
| 0.03 | 0.026 | 0.041 | Trypsin I inhibitor | 0.041 0.016 DBMET02067 | DBMET02067 | |
| 0.018 | 0.014 | 0.068 | Melatonin 3 antagonist | 0.068 0.005 DBMET02067 | DBMET02067 | |
| 0.1 | 0.097 | 0.138 | Nav1.3 sodium channel blocker | 0.138 0.056 DBMET02067 | DBMET02067 | |
| 0.068 | 0.065 | 0.189 | Analgesic, opioid | 0.12 0.022 DBMET02065 0.098 0.032 DBMET02066 0.189 0.01 DBMET02067 | DBMET02067 | |
| 0.018 | 0.015 | 0.018 | Integrin beta3 antagonist | |||
| 0.072 | 0.072 | 0.171 | Opioid kappa receptor antagonist | 0.084 0.052 DBMET02065 0.171 0.013 DBMET02067 | DBMET02067 | |
| 0.049 | 0.051 | 0.297 | Angiotensin-converting enzyme inhibitor | 0.194 0.004 DBMET02065 0.297 0.003 DBMET02066 0.083 0.013 DBMET02067 | DBMET02066 | |
| 0.047 | 0.05 | 0.134 | Aminopeptidase microsomal inhibitor | 0.119 0.013 DBMET02065 0.126 0.012 DBMET02066 0.134 0.01 DBMET02067 | DBMET02067 | |
| 0.021 | 0.028 | 0.076 | Bradykinin B2 receptor antagonist | 0.041 0.015 DBMET02065 0.076 0.004 DBMET02067 | DBMET02067 | |
| 0.044 | 0.051 | 0.196 | Human rhinovirus A protease inhibitor | 0.196 0.006 DBMET02065 0.18 0.007 DBMET02066 0.139 0.009 DBMET02067 | DBMET02065 | |
| 0.036 | 0.044 | 0.063 | HIV-1 protease inhibitor | 0.063 0.01 DBMET02065 0.06 0.012 DBMET02066 | DBMET02065 | |
| 0.047 | 0.056 | 0.11 | Cathepsin B inhibitor | 0.091 0.02 DBMET02065 0.074 0.027 DBMET02066 0.11 0.013 DBMET02067 | DBMET02067 | |
| 0.056 | 0.065 | 0.151 | Histone deacetylase SIRT3 inhibitor | 0.151 0.004 DBMET02067 | DBMET02067 | |
| 0.024 | 0.034 | 0.048 | Gonadotropin-releasing hormone receptor antagonist | 0.029 0.028 DBMET02065 0.048 0.017 DBMET02067 | DBMET02067 | |
| 0.008 | 0.019 | 0.039 | Glucagon agonist | 0.039 0.005 DBMET02065 0.016 0.01 DBMET02066 0.022 0.008 DBMET02067 | DBMET02065 | |
| 0.152 | 0.165 | 0.526 | Interleukin agonist | 0.193 0.127 DBMET02065 0.227 0.097 DBMET02066 0.526 0.007 DBMET02067 | DBMET02067 | |
| 0.023 | 0.038 | 0.152 | Growth hormone releasing factor agonist | 0.041 0.018 DBMET02065 0.152 0.004 DBMET02067 | DBMET02067 | |
| 0.155 | 0.171 | 0.224 | Hypoglycemic | 0.168 0.15 DBMET02065 0.224 0.093 DBMET02066 | DBMET02066 | |
| 0.027 | 0.043 | 0.143 | Bradykinin antagonist | 0.143 0.005 DBMET02067 | DBMET02067 | |
| 0.008 | 0.026 | 0.134 | Protease activated receptor agonist | 0.029 0.008 DBMET02065 0.015 0.014 DBMET02066 0.134 0.003 DBMET02067 | DBMET02067 | |
| 0.01 | 0.028 | 0.055 | Cholecystokinin agonist | 0.055 0.006 DBMET02067 | DBMET02067 | |
| 0.095 | 0.113 | 0.238 | Bone formation stimulant | 0.238 0.027 DBMET02065 0.222 0.03 DBMET02066 0.185 0.04 DBMET02067 | DBMET02065 | |
| 0.004 | 0.024 | 0.027 | Neurokinin 3 agonist | 0.01 0.009 DBMET02065 0.027 0.003 DBMET02067 | DBMET02067 | |
| 0.032 | 0.051 | 0.114 | Aminopeptidase N inhibitor | 0.101 0.013 DBMET02065 0.107 0.012 DBMET02066 0.114 0.01 DBMET02067 | DBMET02067 | |
| 0.039 | 0.063 | 0.052 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.034 DBMET02065 0.052 0.015 DBMET02067 | DBMET02067 | |
| 0.053 | 0.077 | 0.117 | Elastase 1 inhibitor | 0.105 0.018 DBMET02065 0.117 0.013 DBMET02066 | DBMET02066 | |
| 0.032 | 0.059 | 0.187 | GHS receptor agonist | 0.187 0.004 DBMET02067 | DBMET02067 | |
| 0.053 | 0.082 | 0.186 | Histone deacetylase SIRT2 inhibitor | 0.186 0.005 DBMET02067 | DBMET02067 | |
| 0.131 | 0.161 | 0.151 | Catenin beta inhibitor | 0.151 0.103 DBMET02065 0.145 0.117 DBMET02066 0.138 0.137 DBMET02067 | DBMET02065 | |
| 0.024 | 0.056 | 0.064 | Tryptase inhibitor | 0.064 0.008 DBMET02067 | DBMET02067 | |
| 0.129 | 0.162 | 0.451 | Neurotensin receptor agonist | 0.451 0.006 DBMET02065 0.322 0.012 DBMET02066 0.333 0.011 DBMET02067 | DBMET02065 | |
| 0.035 | 0.069 | 0.086 | Bombesin antagonist | 0.064 0.016 DBMET02065 0.058 0.02 DBMET02066 0.086 0.008 DBMET02067 | DBMET02067 | |
| 0.013 | 0.048 | 0.024 | Integrin alphaVbeta3 antagonist | 0.024 0.012 DBMET02067 | DBMET02067 | |
| 0.009 | 0.044 | 0.106 | Neurokinin 1 agonist | 0.106 0.004 DBMET02065 0.024 0.012 DBMET02066 0.06 0.006 DBMET02067 | DBMET02065 | |
| 0.075 | 0.118 | 0.249 | Chelator | 0.102 0.075 DBMET02065 0.094 0.087 DBMET02066 0.249 0.016 DBMET02067 | DBMET02067 | |
| 0.019 | 0.061 | 0.115 | Complement C3a chemotactic receptor antagonist | 0.057 0.023 DBMET02065 0.115 0.005 DBMET02067 | DBMET02067 | |
| 0.049 | 0.093 | 0.071 | CXC chemokine receptor antagonist | 0.071 0.048 DBMET02067 | DBMET02067 | |
| 0.007 | 0.053 | 0.097 | Growth hormone release promoting | 0.097 0.004 DBMET02067 | DBMET02067 | |
| 0.047 | 0.093 | 0.106 | Caspase 9 inhibitor | 0.106 0.012 DBMET02065 0.096 0.015 DBMET02066 0.073 0.029 DBMET02067 | DBMET02065 | |
| 0.003 | 0.05 | 0.023 | Protease activated receptor 1 agonist | 0.023 0.004 DBMET02067 | DBMET02067 | |
| 0.002 | 0.05 | 0.011 | KiSS-1 receptor agonist | 0.011 0.005 DBMET02067 | DBMET02067 | |
| 0.008 | 0.057 | 0.03 | Cholecystokinin A agonist | 0.03 0.005 DBMET02067 | DBMET02067 | |
| 0.028 | 0.083 | 0.086 | Plasminogen activator inhibitor | 0.086 0.022 DBMET02067 | DBMET02067 | |
| 0.012 | 0.069 | 0.061 | Renin inhibitor | 0.061 0.013 DBMET02065 0.053 0.016 DBMET02066 0.054 0.016 DBMET02067 | DBMET02065 | |
| 0.018 | 0.076 | 0.062 | Bombesin 1 receptor antagonist | 0.043 0.019 DBMET02065 0.034 0.03 DBMET02066 0.062 0.007 DBMET02067 | DBMET02067 | |
| 0.044 | 0.104 | 0.204 | Sirtuin 1 inhibitor | 0.115 0.016 DBMET02065 0.094 0.026 DBMET02066 0.204 0.004 DBMET02067 | DBMET02067 | |
| 0.013 | 0.079 | 0.063 | Caspase 2 inhibitor | 0.048 0.012 DBMET02065 0.048 0.012 DBMET02066 0.063 0.008 DBMET02067 | DBMET02067 | |
| 0.005 | 0.072 | 0.042 | Nociceptin (N/OFQ) receptor agonist | 0.042 0.007 DBMET02067 | DBMET02067 | |
| 0.007 | 0.075 | 0.034 | Dipeptidyl peptidase VIII inhibitor | 0.034 0.005 DBMET02067 | DBMET02067 | |
| 0.014 | 0.083 | 0.037 | Complement C5a chemotactic receptor antagonist | 0.037 0.014 DBMET02067 | DBMET02067 | |
| 0.006 | 0.076 | 0.048 | KiSS-1 receptor antagonist | 0.017 0.012 DBMET02065 0.048 0.004 DBMET02067 | DBMET02067 | |
| 0.006 | 0.087 | 0.045 | Human T-cell leukemia virus type I protease inhibitor | 0.045 0.004 DBMET02065 0.042 0.005 DBMET02066 | DBMET02065 | |
| 0.007 | 0.092 | 0.039 | Angiotensin-converting enzyme 2 inhibitor | 0.021 0.008 DBMET02065 0.039 0.004 DBMET02066 | DBMET02066 | |
| 0.016 | 0.102 | 0.24 | Growth hormone secretagogue receptor antagonist | 0.24 0.004 DBMET02067 | DBMET02067 | |
| 0.086 | 0.173 | 0.227 | Cell wall synthesis inhibitor | 0.227 0.021 DBMET02067 | DBMET02067 | |
| 0.008 | 0.097 | 0.098 | Cholecystokinin A antagonist | 0.047 0.021 DBMET02065 0.038 0.025 DBMET02066 0.098 0.009 DBMET02067 | DBMET02067 | |
| 0.01 | 0.1 | 0.089 | Cholecystokinin antagonist | 0.049 0.025 DBMET02065 0.043 0.028 DBMET02066 0.089 0.01 DBMET02067 | DBMET02067 | |
| 0.006 | 0.098 | 0.054 | Cholecystokinin B antagonist | 0.054 0.009 DBMET02067 | DBMET02067 | |
| 0.004 | 0.101 | 0.018 | Carbonic anhydrase IV stimulant | 0.018 0.007 DBMET02067 | DBMET02067 | |
| 0.008 | 0.104 | 0.028 | Bradykinin B1 receptor antagonist | 0.028 0.019 DBMET02067 | DBMET02067 | |
| 0.031 | 0.13 | 0.114 | Carbonic anhydrase II stimulant | 0.054 0.032 DBMET02065 0.114 0.004 DBMET02067 | DBMET02067 | |
| 0.015 | 0.114 | 0.092 | Carbonic anhydrase I stimulant | 0.036 0.028 DBMET02065 0.092 0.005 DBMET02067 | DBMET02067 | |
| 0.009 | 0.109 | 0.106 | Dipeptidyl peptidase I inhibitor | 0.029 0.023 DBMET02065 0.106 0.004 DBMET02067 | DBMET02067 | |
| 0.012 | 0.113 | 0.039 | Plasmepsin I inhibitor | 0.036 0.015 DBMET02065 0.031 0.02 DBMET02066 0.039 0.013 DBMET02067 | DBMET02067 | |
| 0.026 | 0.129 | 0.16 | Selectin antagonist | 0.123 0.022 DBMET02065 0.12 0.022 DBMET02066 0.16 0.016 DBMET02067 | DBMET02067 | |
| 0.01 | 0.113 | 0.154 | Protease activated receptor 1 antagonist | 0.154 0.005 DBMET02067 | DBMET02067 | |
| 0.021 | 0.125 | 0.042 | Antibiotic Aminoglycoside-like | 0.042 0.019 DBMET02067 | DBMET02067 | |
| 0.011 | 0.12 | 0.027 | Cathepsin K inhibitor | 0.027 0.018 DBMET02067 | DBMET02067 | |
| 0.062 | 0.174 | 0.113 | 3C-Like protease (SARS coronavirus) inhibitor | 0.102 0.031 DBMET02065 0.113 0.023 DBMET02066 0.079 0.072 DBMET02067 | DBMET02066 | |
| 0.005 | 0.119 | 0.021 | Integrin alphaVbeta6 antagonist | 0.021 0.005 DBMET02067 | DBMET02067 | |
| 0.069 | 0.183 | 0.151 | Folate antagonist | 0.151 0.022 DBMET02067 | DBMET02067 | |
| 0.025 | 0.142 | 0.048 | Cathepsin F inhibitor | 0.048 0.015 DBMET02067 | DBMET02067 | |
| 0 | 0.118 | 0.004 | Bradykinin B1 receptor agonist | 0.004 0.002 DBMET02067 | DBMET02067 | |
| 0.005 | 0.129 | 0.036 | Dipeptidyl peptidase IX inhibitor | 0.036 0.005 DBMET02067 | DBMET02067 | |
| 0.03 | 0.157 | 0.081 | Histone deacetylase inhibitor | 0.081 0.03 DBMET02067 | DBMET02067 | |
| 0.008 | 0.141 | 0.068 | Lysine carboxypeptidase inhibitor | 0.068 0.005 DBMET02067 | DBMET02067 | |
| 0.008 | 0.144 | 0.025 | Melatonin antagonist | 0.025 0.024 DBMET02067 | DBMET02067 | |
| 0.057 | 0.195 | 0.177 | Vanilloid agonist | 0.079 0.073 DBMET02065 0.177 0.008 DBMET02067 | DBMET02067 | |
| 0.006 | 0.146 | 0.057 | Nociceptin (N/OFQ) receptor antagonist | 0.035 0.025 DBMET02065 0.057 0.011 DBMET02067 | DBMET02067 | |
| 0.157 | 0.299 | 0.247 | Analgesic | 0.247 0.185 DBMET02067 | DBMET02067 | |
| 0.004 | 0.152 | 0.075 | Neutral endopeptidase inhibitor | 0.044 0.008 DBMET02065 0.075 0.005 DBMET02066 | DBMET02066 | |
| 0.101 | 0.251 | 0.224 | Antioxidant | 0.207 0.109 DBMET02065 0.224 0.099 DBMET02066 | DBMET02066 | |
| 0.013 | 0.175 | 0.044 | Opioid kappa receptor agonist | 0.044 0.029 DBMET02067 | DBMET02067 | |
| 0.004 | 0.172 | 0.032 | CXC chemokine 4 receptor agonist | 0.032 0.003 DBMET02067 | DBMET02067 | |
| 0.014 | 0.182 | 0.187 | Endothelin-converting enzyme inhibitor | 0.175 0.006 DBMET02065 0.187 0.005 DBMET02066 0.062 0.024 DBMET02067 | DBMET02066 | |
| 0.079 | 0.249 | 0.182 | Insulin secretagoues | 0.121 0.109 DBMET02065 0.182 0.047 DBMET02066 | DBMET02066 | |
| 0.019 | 0.199 | 0.039 | HCV polyprotein inhibitor | 0.035 0.022 DBMET02065 0.033 0.027 DBMET02066 0.039 0.013 DBMET02067 | DBMET02067 | |
| 0.049 | 0.238 | 0.101 | Transcription factor NF kappa B stimulant | 0.084 0.06 DBMET02065 0.084 0.061 DBMET02066 0.101 0.038 DBMET02067 | DBMET02067 | |
| 0.016 | 0.215 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.017 DBMET02067 | DBMET02067 | |
| 0.011 | 0.224 | 0.051 | Collagenase inhibitor | 0.051 0.03 DBMET02065 0.051 0.03 DBMET02066 0.046 0.041 DBMET02067 | DBMET02066 | |
| 0.009 | 0.223 | 0.06 | Cathepsin L2 inhibitor | 0.04 0.029 DBMET02065 0.06 0.018 DBMET02067 | DBMET02067 | |
| 0.009 | 0.222 | 0.106 | Factor VIIa inhibitor | 0.106 0.011 DBMET02067 | DBMET02067 | |
| 0.063 | 0.282 | 0.221 | Insulin sensitizer | 0.186 0.089 DBMET02066 0.221 0.054 DBMET02067 | DBMET02067 | |
| 0.025 | 0.251 | 0.052 | Parathyroid hormone antagonist | 0.052 0.019 DBMET02067 | DBMET02067 | |
| 0.005 | 0.232 | 0.085 | Leukotriene A4 hydrolase inhibitor | 0.038 0.027 DBMET02065 0.082 0.008 DBMET02066 0.085 0.008 DBMET02067 | DBMET02067 | |
| 0.071 | 0.303 | 0.248 | Free radical scavenger | 0.233 0.076 DBMET02065 0.248 0.069 DBMET02066 | DBMET02066 | |
| 0.018 | 0.25 | 0.089 | Farnesyltransferase inhibitor | 0.088 0.009 DBMET02065 0.089 0.009 DBMET02066 | DBMET02066 | |
| 0.012 | 0.246 | 0.044 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.031 0.013 DBMET02065 0.044 0.006 DBMET02067 | DBMET02067 | |
| 0.008 | 0.245 | 0.021 | Protein 30S ribosomal subunit inhibitor | 0.021 0.02 DBMET02067 | DBMET02067 | |
| 0.033 | 0.303 | 0.297 | Aminoacyl-tRNA synthetase inhibitor | 0.117 0.031 DBMET02065 0.102 0.043 DBMET02066 0.297 0.006 DBMET02067 | DBMET02067 | |
| 0.019 | 0.302 | 0.148 | Dipeptidyl peptidase inhibitor | 0.148 0.005 DBMET02067 | DBMET02067 | |
| 0.001 | 0.306 | 0.012 | Carboxypeptidase B2 inhibitor | 0.012 0.007 DBMET02067 | DBMET02067 | |
| 0.034 | 0.346 | 0.115 | Lipid peroxidase inhibitor | 0.115 0.099 DBMET02066 | DBMET02066 | |
| 0.009 | 0.325 | 0.029 | Caspase 6 inhibitor | 0.029 0.026 DBMET02066 | DBMET02066 | |
| 0.004 | 0.323 | 0.039 | Factor X inhibitor | 0.039 0.027 DBMET02067 | DBMET02067 | |
| 0.076 | 0.407 | 0.18 | Growth factor agonist | 0.18 0.086 DBMET02067 | DBMET02067 | |
| 0.01 | 0.349 | 0.054 | Prolyl endopeptidase inhibitor | 0.054 0.031 DBMET02066 0.051 0.034 DBMET02067 | DBMET02066 | |
| 0.013 | 0.355 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET02067 | DBMET02067 | |
| 0.009 | 0.351 | 0.049 | Carboxypeptidase B inhibitor | 0.049 0.007 DBMET02067 | DBMET02067 | |
| 0.059 | 0.409 | 0.283 | Calpain 2 inhibitor | 0.283 0.125 DBMET02067 | DBMET02067 | |
| 0.007 | 0.37 | 0.095 | Protease activated receptor antagonist | 0.095 0.016 DBMET02067 | DBMET02067 | |
| 0.015 | 0.379 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET02067 | DBMET02067 | |
| 0.009 | 0.377 | 0.06 | Neuraminidase inhibitor | 0.06 0.043 DBMET02066 | DBMET02066 | |
| 0.011 | 0.385 | 0.118 | HCV NS3/NS4A protease inhibitor | 0.118 0.003 DBMET02065 0.104 0.004 DBMET02066 0.076 0.012 DBMET02067 | DBMET02065 | |
| 0.005 | 0.381 | 0.226 | Matrix metalloproteinase 1 inhibitor | 0.226 0.004 DBMET02065 0.17 0.005 DBMET02066 0.064 0.029 DBMET02067 | DBMET02065 | |
| 0.032 | 0.419 | 0.14 | Phospholipase A2 inhibitor | 0.14 0.086 DBMET02067 | DBMET02067 | |
| 0.029 | 0.421 | 0.117 | Falcipain inhibitor | 0.115 0.047 DBMET02065 0.117 0.045 DBMET02066 0.081 0.073 DBMET02067 | DBMET02066 | |
| 0.028 | 0.439 | 0.11 | Falcipain 2 inhibitor | 0.104 0.05 DBMET02065 0.11 0.047 DBMET02066 | DBMET02066 | |
| 0.014 | 0.426 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.023 DBMET02066 | DBMET02066 | |
| 0.024 | 0.445 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET02067 | DBMET02067 | |
| 0.001 | 0.426 | 0.017 | Melatonin 5 antagonist | 0.017 0.005 DBMET02067 | DBMET02067 | |
| 0.013 | 0.442 | 0.209 | Aminopeptidase I inhibitor | 0.194 0.007 DBMET02065 0.209 0.006 DBMET02066 0.19 0.008 DBMET02067 | DBMET02066 | |
| 0.009 | 0.445 | 0.071 | Plasmepsin II inhibitor | 0.056 0.014 DBMET02065 0.071 0.008 DBMET02067 | DBMET02067 | |
| 0.019 | 0.457 | 0.059 | Vanilloid 2 antagonist | 0.056 0.028 DBMET02065 0.059 0.024 DBMET02066 0.049 0.045 DBMET02067 | DBMET02066 | |
| 0.01 | 0.459 | 0.031 | GHS receptor antagonist | 0.031 0.024 DBMET02067 | DBMET02067 | |
| 0.005 | 0.472 | 0.027 | Geranylgeranyltransferase I inhibitor | 0.026 0.01 DBMET02065 0.027 0.009 DBMET02066 | DBMET02066 | |
| 0.007 | 0.476 | 0.351 | Matrix metalloproteinase inhibitor | 0.351 0.004 DBMET02065 0.333 0.004 DBMET02066 0.077 0.039 DBMET02067 | DBMET02065 | |
| 0.009 | 0.48 | 0.222 | Metalloproteinase-9 inhibitor | 0.222 0.007 DBMET02065 0.21 0.008 DBMET02066 0.074 0.049 DBMET02067 | DBMET02065 | |
| 0.04 | 0.533 | 0.447 | Phospholipase C inhibitor | 0.447 0.008 DBMET02067 | DBMET02067 | |
| 0.017 | 0.519 | 0.119 | Bombesin 2 receptor antagonist | 0.072 0.019 DBMET02065 0.051 0.032 DBMET02066 0.119 0.012 DBMET02067 | DBMET02067 | |
| 0.007 | 0.545 | 0.073 | Dipeptidyl peptidase IV inhibitor | 0.073 0.009 DBMET02067 | DBMET02067 | |
| 0.004 | 0.55 | 0.052 | AMPA 2 receptor antagonist | 0.052 0.01 DBMET02067 | DBMET02067 | |
| 0.004 | 0.557 | 0.229 | Cathepsin L inhibitor | 0.229 0.01 DBMET02065 0.084 0.024 DBMET02066 0.122 0.017 DBMET02067 | DBMET02065 | |
| 0.004 | 0.563 | 0.035 | LFA antagonist | 0.035 0.01 DBMET02067 | DBMET02067 | |
| 0.009 | 0.59 | 0.552 | Psychostimulant | 0.552 0.008 DBMET02067 | DBMET02067 | |
| 0.006 | 0.598 | 0.123 | Metalloproteinase-2 inhibitor | 0.104 0.036 DBMET02065 0.123 0.028 DBMET02066 0.103 0.037 DBMET02067 | DBMET02066 | |
| 0.004 | 0.605 | 0.109 | Kinesin antagonist | 0.109 0.007 DBMET02067 | DBMET02067 | |
| 0.004 | 0.605 | 0.109 | Kinesin-like protein 1 inhibitor | 0.109 0.007 DBMET02067 | DBMET02067 | |
| 0.007 | 0.615 | 0.179 | Protein kinase B gamma inhibitor | 0.179 0.01 DBMET02067 | DBMET02067 | |
| 0.004 | 0.636 | 0.129 | Matrix metalloproteinase (membrane-type) inhibitor | 0.107 0.013 DBMET02065 0.129 0.01 DBMET02066 0.057 0.036 DBMET02067 | DBMET02066 | |
| 0.006 | 0.641 | 0.214 | Alkylator | 0.214 0.023 DBMET02067 | DBMET02067 | |
| 0.014 | 0.653 | 0.167 | Acetylcholine M1 receptor antagonist | 0.167 0.061 DBMET02067 | DBMET02067 | |
| 0.016 | 0.658 | 0.099 | Triose-phosphate isomerase inhibitor | 0.099 0.049 DBMET02067 | DBMET02067 | |
| 0.005 | 0.651 | 0.062 | Membrane dipeptidase inhibitor | 0.062 0.009 DBMET02067 | DBMET02067 | |
| 0.003 | 0.658 | 0.264 | NMDA 2A receptor antagonist | 0.264 0.004 DBMET02067 | DBMET02067 | |
| 0.004 | 0.659 | 0.251 | Toll-Like receptor 2 agonist | 0.251 0.004 DBMET02065 0.214 0.006 DBMET02066 0.232 0.005 DBMET02067 | DBMET02065 | |
| 0.008 | 0.67 | 0.128 | Botulinum neurotoxin type A inhibitor | 0.128 0.005 DBMET02067 | DBMET02067 | |
| 0.002 | 0.672 | 0.088 | Cathepsin L1 inhibitor | 0.068 0.014 DBMET02065 0.088 0.011 DBMET02067 | DBMET02067 | |
| 0.016 | 0.695 | 0.247 | Transcription factor NF kappa B inhibitor | 0.247 0.129 DBMET02067 | DBMET02067 | |
| 0.033 | 0.713 | 0.284 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.284 0.076 DBMET02067 | DBMET02067 | |
| 0.006 | 0.701 | 0.327 | Carbonic anhydrase stimulant | 0.327 0.004 DBMET02067 | DBMET02067 | |
| 0.013 | 0.71 | 0.358 | Thiol protease inhibitor | 0.358 0.015 DBMET02065 0.311 0.018 DBMET02066 0.358 0.015 DBMET02067 | DBMET02067 | |
| 0.012 | 0.715 | 0.309 | Aminopeptidase B inhibitor | 0.211 0.019 DBMET02065 0.28 0.01 DBMET02066 0.309 0.008 DBMET02067 | DBMET02067 | |
| 0.013 | 0.72 | 0.447 | Antiamyloidogenic | 0.383 0.032 DBMET02065 0.293 0.054 DBMET02066 0.447 0.022 DBMET02067 | DBMET02067 | |
| 0.003 | 0.714 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 DBMET02067 | DBMET02067 | |
| 0.003 | 0.716 | 0.102 | Dipeptidyl peptidase II inhibitor | 0.102 0.004 DBMET02067 | DBMET02067 | |
| 0.003 | 0.717 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 DBMET02067 | DBMET02067 | |
| 0.03 | 0.745 | 0.104 | Glutamate release inhibitor | 0.104 0.036 DBMET02067 | DBMET02067 | |
| 0.003 | 0.734 | 0.262 | Neutrophil collagenase inhibitor | 0.231 0.006 DBMET02065 0.262 0.005 DBMET02066 0.086 0.028 DBMET02067 | DBMET02066 | |
| 0.005 | 0.738 | 0.307 | NMDA receptor agonist | 0.307 0.003 DBMET02067 | DBMET02067 | |
| 0.007 | 0.74 | 0.136 | Protease 3C (Human rhinovirus) inhibitor | 0.099 0.016 DBMET02065 0.136 0.008 DBMET02066 0.122 0.009 DBMET02067 | DBMET02066 | |
| 0.011 | 0.756 | 0.097 | Telomerase inhibitor | 0.097 0.035 DBMET02067 | DBMET02067 | |
| 0.002 | 0.759 | 0.101 | Metalloproteinase-3 inhibitor | 0.093 0.012 DBMET02065 0.101 0.01 DBMET02066 0.046 0.038 DBMET02067 | DBMET02066 | |
| 0.01 | 0.767 | 0.058 | CD45 antagonist | 0.049 0.037 DBMET02065 0.056 0.026 DBMET02066 0.058 0.023 DBMET02067 | DBMET02067 | |
| 0.012 | 0.773 | 0.194 | Interleukin 6 antagonist | 0.194 0.045 DBMET02067 | DBMET02067 | |
| 0.005 | 0.767 | 0.143 | Protein kinase A inhibitor | 0.143 0.026 DBMET02067 | DBMET02067 | |
| 0.002 | 0.766 | 0.026 | Protease (Human cytomegalovirus) inhibitor | 0.026 0.011 DBMET02067 | DBMET02067 | |
| 0.014 | 0.786 | 0.181 | Cyclooxygenase 3 inhibitor | 0.181 0.027 DBMET02067 | DBMET02067 | |
| 0.006 | 0.791 | 0.166 | Spasmolytic | 0.166 0.149 DBMET02067 | DBMET02067 | |
| 0.005 | 0.79 | 0.14 | Neuropeptide Y antagonist | 0.14 0.024 DBMET02067 | DBMET02067 | |
| 0.007 | 0.796 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.025 DBMET02067 | DBMET02067 | |
| 0.001 | 0.801 | 0.371 | Ribonucleotide reductase inhibitor | 0.371 0.003 DBMET02065 0.3 0.004 DBMET02066 0.151 0.012 DBMET02067 | DBMET02065 | |
| 0.003 | 0.809 | 0.145 | Factor XIIIa inhibitor | 0.145 0.004 DBMET02065 0.138 0.004 DBMET02067 | DBMET02065 | |
| 0.007 | 0.813 | 0.588 | Transcription factor STAT3 inhibitor | 0.588 0.004 DBMET02065 0.49 0.007 DBMET02066 0.253 0.081 DBMET02067 | DBMET02065 | |
| 0.013 | 0.819 | 0.194 | Vanilloid 1 agonist | 0.194 0.014 DBMET02067 | DBMET02067 | |
| 0.002 | 0.811 | 0.05 | Peptide deformylase inhibitor | 0.05 0.01 DBMET02065 0.044 0.013 DBMET02067 | DBMET02065 | |
| 0.017 | 0.83 | 0.554 | Superoxide dismutase inhibitor | 0.212 0.105 DBMET02065 0.188 0.132 DBMET02066 0.554 0.009 DBMET02067 | DBMET02067 | |
| 0.008 | 0.822 | 0.319 | Cathepsin H inhibitor | 0.154 0.044 DBMET02065 0.164 0.037 DBMET02066 0.319 0.009 DBMET02067 | DBMET02067 | |
| 0.005 | 0.823 | 0.167 | Falcipain 3 inhibitor | 0.167 0.029 DBMET02067 | DBMET02067 | |
| 0.004 | 0.824 | 0.264 | Anticonvulsant | 0.264 0.052 DBMET02067 | DBMET02067 | |
| 0.005 | 0.834 | 0.085 | Protein kinase C iota inhibitor | 0.085 0.024 DBMET02067 | DBMET02067 | |
| 0.01 | 0.839 | 0.144 | Melanin inhibitor | 0.144 0.091 DBMET02067 | DBMET02067 | |
| 0.001 | 0.831 | 0.361 | Ribonucleoside-diphosphate reductase inhibitor | 0.361 0.003 DBMET02065 0.308 0.004 DBMET02066 0.142 0.012 DBMET02067 | DBMET02065 | |
| 0.001 | 0.832 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.011 DBMET02067 | DBMET02067 | |
| 0.029 | 0.86 | 0.159 | Death-associated protein kinase 2 inhibitor | 0.159 0.087 DBMET02067 | DBMET02067 | |
| 0 | 0.831 | 0.134 | Aminopeptidase A inhibitor | 0.031 0.006 DBMET02065 0.134 0.002 DBMET02066 0.026 0.008 DBMET02067 | DBMET02066 | |
| 0.006 | 0.844 | 0.298 | Toll-Like receptor 2 antagonist | 0.298 0.005 DBMET02067 | DBMET02067 | |
| 0.004 | 0.843 | 0.117 | Interferon agonist | 0.117 0.019 DBMET02067 | DBMET02067 | |
| 0.002 | 0.85 | 0.141 | NMDA receptor antagonist | 0.141 0.027 DBMET02067 | DBMET02067 | |
| 0 | 0.848 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET02067 | DBMET02067 | |
| 0.008 | 0.858 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.073 0.024 DBMET02067 | DBMET02067 | |
| 0.005 | 0.859 | 0.109 | Thrombin receptor antagonist | 0.109 0.003 DBMET02067 | DBMET02067 | |
| 0.006 | 0.87 | 0.103 | Prolactin inhibitor | 0.103 0.052 DBMET02067 | DBMET02067 | |
| 0.003 | 0.874 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DBMET02067 | DBMET02067 | |
| 0.003 | 0.877 | 0.32 | Nitric-oxide synthase inhibitor | 0.32 0.004 DBMET02067 | DBMET02067 | |
| 0.007 | 0.883 | 0.23 | Adenylate cyclase stimulant | 0.23 0.005 DBMET02067 | DBMET02067 | |
| 0.006 | 0.884 | 0.575 | Transcription factor STAT inhibitor | 0.575 0.004 DBMET02065 0.431 0.014 DBMET02066 0.306 0.052 DBMET02067 | DBMET02065 | |
| 0.003 | 0.887 | 0.155 | Anesthetic general | 0.155 0.108 DBMET02067 | DBMET02067 | |
| 0.001 | 0.888 | 0.347 | Ornithine carbamoyltransferase inhibitor | 0.347 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.89 | 0.104 | Sirtuin 2 inhibitor | 0.104 0.004 DBMET02067 | DBMET02067 | |
| 0.002 | 0.892 | 0.299 | Glutamate decarboxylase inhibitor | 0.299 0.004 DBMET02067 | DBMET02067 | |
| 0.002 | 0.894 | 0.291 | Catalase inhibitor | 0.136 0.029 DBMET02065 0.291 0.006 DBMET02066 0.192 0.017 DBMET02067 | DBMET02066 | |
| 0.006 | 0.9 | 0.204 | Antipruritic | 0.204 0.046 DBMET02067 | DBMET02067 | |
| 0.019 | 0.927 | 0.196 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.196 0.094 DBMET02067 | DBMET02067 | |
| 0.003 | 0.912 | 0.142 | Mucolytic | 0.142 0.037 DBMET02067 | DBMET02067 | |
| 0.005 | 0.915 | 0.247 | DNA damaging | 0.247 0.082 DBMET02067 | DBMET02067 | |
| 0.009 | 0.923 | 0.141 | Transcription factor STAT6 inhibitor | 0.141 0.031 DBMET02067 | DBMET02067 | |
| 0.001 | 0.918 | 0.201 | Glycine transporter 2 inhibitor | 0.201 0.005 DBMET02067 | DBMET02067 | |
| 0.002 | 0.926 | 0.102 | Expectorant | 0.102 0.066 DBMET02067 | DBMET02067 | |
| 0.001 | 0.928 | 0.162 | NMDA 2 receptor antagonist | 0.162 0.014 DBMET02067 | DBMET02067 | |
| 0.002 | 0.929 | 0.134 | Epithelial sodium channel blocker | 0.134 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.931 | 0.049 | Factor Xa inhibitor | 0.049 0.03 DBMET02067 | DBMET02067 | |
| 0.002 | 0.94 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET02067 | DBMET02067 | |
| 0.003 | 0.942 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.057 DBMET02067 | DBMET02067 | |
| 0.002 | 0.945 | 0.077 | Interferon inducer | 0.077 0.027 DBMET02067 | DBMET02067 | |
| 0.001 | 0.944 | 0.053 | Mannosidase inhibitor | 0.053 0.023 DBMET02067 | DBMET02067 | |
| 0.001 | 0.944 | 0.115 | NMDA receptor glycine site agonist | 0.115 0.01 DBMET02067 | DBMET02067 | |
| 0.002 | 0.946 | 0.257 | Inducible nitric-oxide synthase inhibitor | 0.257 0.005 DBMET02067 | DBMET02067 | |
| 0.001 | 0.945 | 0.088 | Cyclin A1 inhibitor | 0.088 0.011 DBMET02067 | DBMET02067 | |
| 0.001 | 0.947 | 0.023 | Toll-Like receptor 8 agonist | 0.023 0.009 DBMET02067 | DBMET02067 | |
| 0.002 | 0.95 | 0.072 | Secretase beta inhibitor | 0.072 0.046 DBMET02067 | DBMET02067 | |
| 0 | 0.949 | 0.097 | Arginase inhibitor | 0.097 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.95 | 0.02 | Geranylgeranyltransferase inhibitor | 0.02 0.018 DBMET02066 | DBMET02066 | |
| 0.001 | 0.951 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET02067 | DBMET02067 | |
| 0 | 0.952 | 0.16 | AMPA 1 receptor antagonist | 0.16 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.954 | 0.302 | Histidine decarboxylase inhibitor | 0.302 0.006 DBMET02067 | DBMET02067 | |
| 0 | 0.954 | 0.06 | Diamine oxidase inhibitor | 0.06 0.01 DBMET02067 | DBMET02067 | |
| 0.001 | 0.954 | 0.128 | Cannabinoid CB1 receptor agonist | 0.128 0.013 DBMET02067 | DBMET02067 | |
| 0.001 | 0.955 | 0.073 | AMPA 3 receptor antagonist | 0.073 0.005 DBMET02067 | DBMET02067 | |
| 0.003 | 0.958 | 0.328 | Glutamate dehydrogenase inhibitor | 0.328 0.005 DBMET02067 | DBMET02067 | |
| 0.003 | 0.961 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.018 DBMET02067 | DBMET02067 | |
| 0.001 | 0.959 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET02067 | DBMET02067 | |
| 0.005 | 0.964 | 0.127 | Glutamate (mGluR7) agonist | 0.127 0.024 DBMET02067 | DBMET02067 | |
| 0.001 | 0.96 | 0.072 | Antimetabolite | 0.072 0.021 DBMET02067 | DBMET02067 | |
| 0 | 0.96 | 0.045 | Kainate receptor 1 antagonist | 0.045 0.006 DBMET02067 | DBMET02067 | |
| 0.011 | 0.97 | 0.255 | Histamine release inhibitor | 0.255 0.152 DBMET02067 | DBMET02067 | |
| 0 | 0.96 | 0.029 | Myristoyl transferase inhibitor | 0.029 0.014 DBMET02067 | DBMET02067 | |
| 0.007 | 0.968 | 0.254 | Gastrin inhibitor | 0.254 0.074 DBMET02067 | DBMET02067 | |
| 0.018 | 0.981 | 0.186 | Nitric-oxide synthase stimulant | 0.186 0.115 DBMET02067 | DBMET02067 | |
| 0.004 | 0.967 | 0.156 | Interleukin 8 antagonist | 0.156 0.03 DBMET02067 | DBMET02067 | |
| 0.007 | 0.97 | 0.137 | Interferon gamma antagonist | 0.137 0.097 DBMET02067 | DBMET02067 | |
| 0.004 | 0.97 | 0.09 | Anabolic | 0.09 0.079 DBMET02067 | DBMET02067 | |
| 0.002 | 0.969 | 0.113 | Caspase 3 inhibitor | 0.113 0.07 DBMET02066 | DBMET02066 | |
| 0.001 | 0.968 | 0.076 | Histamine H2 receptor antagonist | 0.076 0.074 DBMET02067 | DBMET02067 | |
| 0.002 | 0.969 | 0.119 | Carbonic anhydrase XV inhibitor | 0.119 0.048 DBMET02067 | DBMET02067 | |
| 0.008 | 0.975 | 0.349 | Tyrosine 3 hydroxylase inhibitor | 0.349 0.016 DBMET02067 | DBMET02067 | |
| 0.003 | 0.97 | 0.236 | DNA synthesis inhibitor | 0.236 0.077 DBMET02067 | DBMET02067 | |
| 0.001 | 0.968 | 0.091 | Histamine H2 receptor agonist | 0.091 0.005 DBMET02067 | DBMET02067 | |
| 0.001 | 0.968 | 0.118 | AMPA 4 receptor antagonist | 0.118 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.969 | 0.1 | GABA B receptor agonist | 0.1 0.017 DBMET02067 | DBMET02067 | |
| 0.001 | 0.969 | 0.094 | Phenylalanine 4-hydroxylase inhibitor | 0.094 0.029 DBMET02067 | DBMET02067 | |
| 0.015 | 0.984 | 0.48 | 5 Hydroxytryptamine release stimulant | 0.48 0.031 DBMET02067 | DBMET02067 | |
| 0.002 | 0.971 | 0.113 | Mediator release inhibitor | 0.113 0.055 DBMET02067 | DBMET02067 | |
| 0 | 0.97 | 0.045 | Purinergic P2Y15 antagonist | 0.045 0.005 DBMET02067 | DBMET02067 | |
| 0 | 0.971 | 0.07 | Endothelial nitric-oxide synthase inhibitor | 0.07 0.005 DBMET02067 | DBMET02067 | |
| 0.009 | 0.979 | 0.195 | Heat shock protein 70 antagonist | 0.195 0.007 DBMET02067 | DBMET02067 | |
| 0.006 | 0.978 | 0.153 | Photosensitizer | 0.153 0.029 DBMET02067 | DBMET02067 | |
| 0.009 | 0.981 | 0.199 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 DBMET02067 | DBMET02067 | |
| 0.001 | 0.973 | 0.148 | Sphingosine 1-phosphate receptor 2 antagonist | 0.148 0.043 DBMET02067 | DBMET02067 | |
| 0.001 | 0.973 | 0.049 | Histamine agonist | 0.049 0.042 DBMET02067 | DBMET02067 | |
| 0 | 0.973 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET02067 | DBMET02067 | |
| 0 | 0.973 | 0.029 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.974 | 0.074 | Cyclin A inhibitor | 0.074 0.035 DBMET02067 | DBMET02067 | |
| 0 | 0.974 | 0.108 | Kainate receptor antagonist | 0.108 0.007 DBMET02067 | DBMET02067 | |
| 0 | 0.974 | 0.112 | Acyl-CoA dehydrogenase inhibitor | 0.112 0.014 DBMET02067 | DBMET02067 | |
| 0.003 | 0.977 | 0.17 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.17 0.021 DBMET02067 | DBMET02067 | |
| 0.003 | 0.977 | 0.127 | Glutathione S-transferase inhibitor | 0.127 0.019 DBMET02067 | DBMET02067 | |
| 0.001 | 0.976 | 0.073 | Cyclin A2 inhibitor | 0.073 0.036 DBMET02067 | DBMET02067 | |
| 0.002 | 0.978 | 0.097 | Vanilloid 4 agonist | 0.097 0.019 DBMET02067 | DBMET02067 | |
| 0 | 0.977 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET02067 | DBMET02067 | |
| 0.004 | 0.981 | 0.159 | Adenylate kinase inhibitor | 0.159 0.023 DBMET02067 | DBMET02067 | |
| 0.001 | 0.978 | 0.073 | Glutamate (mGluR4) antagonist | 0.073 0.01 DBMET02067 | DBMET02067 | |
| 0 | 0.978 | 0.068 | Alcohol oxidase inhibitor | 0.068 0.03 DBMET02067 | DBMET02067 | |
| 0.001 | 0.978 | 0.164 | Ferrochelatase inhibitor | 0.164 0.032 DBMET02067 | DBMET02067 | |
| 0.003 | 0.981 | 0.115 | Antibacterial (Helicobacter pylori) | 0.115 0.09 DBMET02067 | DBMET02067 | |
| 0 | 0.978 | 0.05 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET02067 | DBMET02067 | |
| 0 | 0.978 | 0.141 | Argininosuccinate synthase inhibitor | 0.141 0.012 DBMET02067 | DBMET02067 | |
| 0.001 | 0.979 | 0.479 | GABA C receptor agonist | 0.479 0.004 DBMET02067 | DBMET02067 | |
| 0.001 | 0.979 | 0.151 | GABA aminotransferase inhibitor | 0.151 0.008 DBMET02067 | DBMET02067 | |
| 0.001 | 0.98 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.068 DBMET02067 | DBMET02067 | |
| 0.003 | 0.983 | 0.145 | Carbonic anhydrase III inhibitor | 0.145 0.03 DBMET02067 | DBMET02067 | |
| 0.002 | 0.982 | 0.363 | Peroxidase inhibitor | 0.363 0.026 DBMET02067 | DBMET02067 | |
| 0 | 0.98 | 0.05 | Methionyl aminopeptidase 1 inhibitor | 0.05 0.006 DBMET02067 | DBMET02067 | |
| 0.001 | 0.981 | 0.117 | Myeloperoxidase inhibitor | 0.117 0.021 DBMET02067 | DBMET02067 | |
| 0.002 | 0.983 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.061 DBMET02067 | DBMET02067 | |
| 0.002 | 0.982 | 0.077 | Glycine receptor agonist | 0.077 0.042 DBMET02067 | DBMET02067 | |
| 0.001 | 0.982 | 0.122 | Histamine N-methyltransferase inhibitor | 0.122 0.028 DBMET02067 | DBMET02067 | |
| 0.001 | 0.982 | 0.195 | GABA C receptor antagonist | 0.195 0.014 DBMET02067 | DBMET02067 | |
| 0 | 0.981 | 0.036 | Kainate receptor 2 antagonist | 0.036 0.025 DBMET02067 | DBMET02067 | |
| 0 | 0.982 | 0.039 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET02067 | DBMET02067 | |
| 0 | 0.982 | 0.039 | Carbonic anhydrase IV inhibitor | 0.039 0.034 DBMET02067 | DBMET02067 | |
| 0.001 | 0.983 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET02067 | DBMET02067 | |
| 0.001 | 0.984 | 0.074 | Glutamate (mGluR6) antagonist | 0.074 0.033 DBMET02067 | DBMET02067 | |
| 0 | 0.984 | 0.041 | Thymidylate synthase inhibitor | 0.041 0.04 DBMET02067 | DBMET02067 | |
| 0 | 0.984 | 0.054 | Biliverdin reductase inhibitor | 0.054 0.047 DBMET02067 | DBMET02067 | |
| 0 | 0.984 | 0.059 | Histamine H1 receptor agonist | 0.059 0.009 DBMET02067 | DBMET02067 | |
| 0 | 0.984 | 0.021 | Glutamate (mGluR1a) agonist | 0.021 0.017 DBMET02067 | DBMET02067 | |
| 0.001 | 0.985 | 0.05 | AICAR transformylase inhibitor | 0.05 0.023 DBMET02067 | DBMET02067 | |
| 0 | 0.985 | 0.044 | Calcium-sensing receptor agonist | 0.044 0.006 DBMET02067 | DBMET02067 | |
| 0.001 | 0.985 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.033 DBMET02067 | DBMET02067 | |
| 0 | 0.985 | 0.073 | AMPA receptor antagonist | 0.073 0.019 DBMET02067 | DBMET02067 | |
| 0.001 | 0.986 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.106 DBMET02067 | DBMET02067 | |
| 0 | 0.986 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.024 DBMET02067 | DBMET02067 | |
| 0.001 | 0.987 | 0.175 | GABA C receptor rho-1 antagonist | 0.175 0.013 DBMET02067 | DBMET02067 | |
| 0.001 | 0.987 | 0.044 | Kainate receptor agonist | 0.044 0.022 DBMET02067 | DBMET02067 | |
| 0 | 0.987 | 0.129 | Carbamoyl phosphate synthetase inhibitor | 0.129 0.014 DBMET02067 | DBMET02067 | |
| 0.001 | 0.988 | 0.083 | Creatine kinase inhibitor | 0.083 0.082 DBMET02067 | DBMET02067 | |
| 0 | 0.987 | 0.097 | Phosphofructokinase-1 inhibitor | 0.097 0.033 DBMET02067 | DBMET02067 | |
| 0.003 | 0.991 | 0.344 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.344 0.158 DBMET02067 | DBMET02067 | |
| 0.001 | 0.988 | 0.114 | Protein kinase C gamma inhibitor | 0.114 0.058 DBMET02067 | DBMET02067 | |
| 0.002 | 0.99 | 0.266 | 5 Hydroxytryptamine release inhibitor | 0.266 0.207 DBMET02067 | DBMET02067 | |
| 0 | 0.988 | 0.045 | Glutamate (mGluR8) agonist | 0.045 0.016 DBMET02067 | DBMET02067 | |
| 0 | 0.988 | 0.089 | Porphobilinogen synthase inhibitor | 0.089 0.041 DBMET02067 | DBMET02067 | |
| 0 | 0.988 | 0.023 | Vanilloid 2 agonist | 0.023 0.022 DBMET02067 | DBMET02067 | |
| 0.004 | 0.993 | 0.354 | 5 Hydroxytryptamine uptake stimulant | 0.354 0.024 DBMET02067 | DBMET02067 | |
| 0.001 | 0.99 | 0.319 | GABA C receptor rho-3 antagonist | 0.319 0.103 DBMET02067 | DBMET02067 | |
| 0 | 0.989 | 0.04 | Fumarate hydratase inhibitor | 0.04 0.019 DBMET02067 | DBMET02067 | |
| 0 | 0.989 | 0.058 | Glutamate (mGluR1) antagonist | 0.058 0.041 DBMET02067 | DBMET02067 | |
| 0 | 0.989 | 0.112 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 DBMET02067 | DBMET02067 | |
| 0.001 | 0.99 | 0.231 | Alpha-N-acetylglucosaminidase inhibitor | 0.231 0.026 DBMET02067 | DBMET02067 | |
| 0 | 0.99 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.041 DBMET02067 | DBMET02067 | |
| 0.001 | 0.991 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.06 DBMET02067 | DBMET02067 | |
| 0 | 0.994 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.088 DBMET02067 | DBMET02067 | |
| 0.001 | 0.995 | 0.109 | Beta amyloid protein antagonist | 0.109 0.079 DBMET02067 | DBMET02067 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |